18.12.2012 Views

biotechnology symposium 2005 abstracts - Universität Leipzig

biotechnology symposium 2005 abstracts - Universität Leipzig

biotechnology symposium 2005 abstracts - Universität Leipzig

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

4.6 Recombinant expression and structure<br />

determination of phosphodiesterases<br />

Roy Eylenstein Eylenstein, Nancy Kühn, Petra Schäfer, E. Bartholomeus<br />

Küttner, Susanne Moschütz, Norbert Sträter<br />

PDEs catalyzing the hydrolysis of the 3’-5’ phosphodiester bond of cyclic nucleotides<br />

(cAMP, cGMP) comprise a family of enzymes that modulate the immune response,<br />

infl ammation, cell growth and many other functions. 11 families of PDEs have been<br />

described including multiple isoforms with varying selectivities for cAMP and/or cGMP.<br />

The isoforms are differentially expressed and regulated in different cell types, and they<br />

appear to modulate the location, substrate selectivity, kinetics, and response to activators<br />

or inhibitors of the enzyme. As essential regulators of cyclic nucleotide signalling, PDEs<br />

are recognized as important drug targets for the treatment of diseases such as heart failure,<br />

asthma and erectile dysfunction.<br />

The aim of the current project is to develop expression constructs for the production<br />

of suffi cient material for crystallization of full length PDEs and catalytic domains. The<br />

X-ray structures of these PDEs will allow for the rational design of specifi c inhibitors as<br />

therapeutics. 3D structures of the catalytic domains of PDE1, -3, -4, -5 and -9 are currently<br />

available.<br />

For the expression of the catalytic domains we designed different truncations of PDEs<br />

to fi nd good constructs for subsequent protein purifi cation and crystallization. Expression<br />

in E. coli as well as in P. pastoris often yields insoluble products. To avoid the refolding<br />

processes of the proteins we also try to express the catalytic domains in an E. coli based<br />

cell-free in vitro system. This system allows for the simple modifi cation of many expression<br />

parameters and hence it is maybe possible to directly produce soluble and active protein.<br />

Roy Eylenstein<br />

<strong>Universität</strong> <strong>Leipzig</strong><br />

Center for Biotechnology and Biomedicine (BBZ)<br />

Professorship for Structural Analysis of Biopolymers<br />

and<br />

Faculty of Chemistry and Mineralogy<br />

E-Mail: roy.eylenstein@bbz.uni-leipzig.de<br />

www.uni-leipzig.de/~strater/<br />

49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!